Under the main topic “Traumatology and Orthopedics of the Hip”, the invited experts presented the latest gold standard and the latest scientific findings on injuries and diseases of the hip joint. There were also meetings of the working groups, in particular geriatrics, discussion rounds and meetings of the “Young ÖGU Forum” and the “Young ÖGout”.
A great scientific program was offered, which, with over 100 contributions and lectures by experts, spanned a bridge between illness, malformation and injury.
Haemo Pharma Lunch Symposium
On the topic of “Autologous Cell Therapy 3.0 - Indication-Based Treatment Strategies with IMPACT,” Dr. Kalojan Petkin explained the therapeutic benefits of the fully automated IMPACT system.
With the IMPACT system, various autologous cell therapies can be offered with just one platform. Autologous blood products — also known internationally as “orthobiologics” — use the body's own regeneration mechanisms to produce growth factors, anti-inflammatory cytokines or stem cells in concentrated form, for example. After an autologous, centrifuged blood injection into the defect, these support the body in healing injured tissue in a purely natural way.
Learn more about the Impact system.
Further information, as well as the program of the event, can be found here:
58th ÖGU & 3rd ÖGout Annual Meeting 2022
More posts
Long-term study proves lasting success with HyaloFast
Haemo Pharma as ADMIRA Wacker's new healthcare partner
